Polygala caudata
Polygala caudata · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Polygala caudata is a medicinal plant known for the significant therapeutic potential found within its roots. The roots contain bioactive compounds, most notably euxanthone and 1,7-dihydroxyxanthone, which drive its pharmacological effects. Research suggests that preparations from these roots can play a crucial role in supporting cell survival and mitigating inflammation. Furthermore, this plant shows promise in addressing complex medical conditions, including central nervous system disorders and epithelial ovarian cancer. Through these diverse biological activities, Polygala caudata remains a subject of intense scientific interest.
- Synonyms
- Heterosamara Caudata · Polygala Comesperma
- Common names
- Not available
- Family
- Polygalaceae
- Distribution
- Not available
- Plant Parts
- Root
Classification
Synonyms
Polygala caudata is a botanical species that is frequently identified through various taxonomic classifications. Within scientific literature, this plant is known by the synonym Heterosamara caudata. It is also recognized under the alternative name Polygala comesperma in certain botanical contexts. These varying designations highlight the complex history of its nomenclature. Understanding these synonyms is essential for accurate identification in both field studies and academic research.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Polygala caudata is a distinctive botanical specimen that belongs to the vast kingdom Plantae. Within this kingdom, it is classified under the class Equisetopsida and the order Fabales. As a member of the genus Polygala, it exhibits specific morphological traits unique to its lineage. This plant is further categorized into the family Polygalaceae, which defines its close evolutionary relatives. Understanding these taxonomic relationships provides essential insight into the biological identity of this species.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Polygalaceae |
| Genus | Polygala |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Polygala caudata is a plant species primarily found within the temperate regions of Asia. Its natural distribution is concentrated heavily within China, where it thrives in diverse environments. Specifically, this species can be identified throughout the South-Central parts of the country. Additionally, it maintains a presence across the Southeast regions of China as well. These specific geographical ranges highlight the plant's localized importance within its native habitat.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Polygala caudata is a self-supporting plant that maintains a distinct shrub-like growth form. This structure allows it to stand firmly within its natural habitat without the need for external support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Polygala caudata is a medicinal plant known to contain the bioactive xanthone derivative euxanthone. Research indicates that this specific compound possesses significant neuropharmacological properties, such as the ability to stimulate neurite outgrowth and promote neuronal differentiation. Beyond its effects on the nervous system, euxanthone has also demonstrated potential in oncology by inducing apoptosis in epithelial ovarian cancer cells. It achieves this anti-tumor effect by inhibiting glycolysis through the downregulation of hexokinase 2. Collectively, these findings highlight the diverse therapeutic potential of the compounds derived from this plant.
Conditions
Polygala caudata contains euxanthone, an active ingredient that demonstrates significant anti-cancer activities by inhibiting glycolysis and inducing apoptosis. This medicinal plant exhibits a potent anti-neoplastic effect, specifically targeting epithelial ovarian cancer cells. Research indicates that its constituents effectively treat both A2780 and SKOV3 cell lines through the downregulation of HK2. Beyond its oncological potential, the genus is traditionally recognized for its ability to treat various cardiovascular disorders.
Preparations
Polygala caudata is prepared as roots for the purpose of isolating various xanthone compounds. These specific xanthones, including several new and known structures, are extracted directly from the plant's root system. Once isolated, these root-derived substances are tested for their significant antioxidation and vasodilatation activities. The research demonstrates that the chemical components found within the roots serve as effective scavengers for reactive oxygen free radicals. Consequently, the roots of this plant act as a vital source for bioactive molecules with therapeutic potential.
Parts used
Polygala caudata is a plant species of significant pharmacological interest, particularly regarding its medicinal components. Researchers have successfully isolated several xanthones specifically from the roots of this plant. These extracted compounds, including both new and known structures, demonstrate potent antioxidation activities in vitro. Furthermore, the study highlights their ability to act as H2O2 scavengers and neutralize reactive oxygen free radicals. Beyond antioxidant properties, these root-derived xanthones also exhibit notable vasodilatation effects by relaxing aortic ring contractions.